Rita Frangiamore

1.4k total citations
24 papers, 291 citations indexed

About

Rita Frangiamore is a scholar working on Neurology, Pathology and Forensic Medicine and Infectious Diseases. According to data from OpenAlex, Rita Frangiamore has authored 24 papers receiving a total of 291 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Neurology, 7 papers in Pathology and Forensic Medicine and 5 papers in Infectious Diseases. Recurrent topics in Rita Frangiamore's work include Myasthenia Gravis and Thymoma (14 papers), Peripheral Neuropathies and Disorders (6 papers) and Antifungal resistance and susceptibility (5 papers). Rita Frangiamore is often cited by papers focused on Myasthenia Gravis and Thymoma (14 papers), Peripheral Neuropathies and Disorders (6 papers) and Antifungal resistance and susceptibility (5 papers). Rita Frangiamore collaborates with scholars based in Italy, United Kingdom and United States. Rita Frangiamore's co-authors include Renato Mantegazza, Paola Cavalcante, Carlo Antozzi, Fiammetta Vanoli, Silvia Bonanno, Pia Bernasconi, Greta Brenna, Lorenzo Maggi, Letizia Scandiffio and Francesca Andreetta and has published in prestigious journals such as SHILAP Revista de lepidopterología, Frontiers in Immunology and Journal of the Neurological Sciences.

In The Last Decade

Rita Frangiamore

22 papers receiving 288 citations

Peers

Countries citing papers authored by Rita Frangiamore

Since Specialization

Citations

This map shows the geographic impact of Rita Frangiamore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rita Frangiamore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rita Frangiamore more than expected).

Fields of papers citing papers by Rita Frangiamore

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rita Frangiamore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rita Frangiamore. The network helps show where Rita Frangiamore may publish in the future.

Co-authorship network of co-authors of Rita Frangiamore

This figure shows the co-authorship network connecting the top 25 collaborators of Rita Frangiamore. A scholar is included among the top collaborators of Rita Frangiamore based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rita Frangiamore. Rita Frangiamore is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Unknown Immunoregulatory Effects of FcRn Inhibition by Efgartigimod in Myasthenia Gravis 2025 ·Neurology Neuroimmunology & Neuroinflammation ·(unknown), Elena Rinaldi, Rita Frangiamore, Fiammetta Vanoli, (unknown), (unknown), (unknown), Francesca Andreetta, Emilio Ciusani, Silvia Bonanno, Lorenzo Maggi, Fulvio Baggi, Renato Mantegazza, Carlo Antozzi, Paola Cavalcante	2
2	Efgartigimod improves non-AChR generalized Myasthenia Gravis: a real world experience 2025 ·Neurological Sciences ·Carlo Antozzi, Rita Frangiamore, Elena Rinaldi, Fiammetta Vanoli, Francesca Andreetta, (unknown), Emilio Ciusani, Silvia Bonanno, Lorenzo Maggi, Renato Mantegazza	1
3	502P Cognitive functioning in myasthenia gravis: an Italian cohort study 2024 ·Neuromuscular Disorders ·(unknown), Alberto Raggi, (unknown), (unknown), Arianna Fornari, Marco Leonardi, Lorenzo Maggi, (unknown), Renato Mantegazza, Carlo Antozzi, Fiammetta Vanoli, Rita Frangiamore	1
4	Concordance between patient‐ and physician‐reported Myasthenia Gravis Activities of Daily Living (MG‐ADL) scores 2023 ·Muscle & Nerve ·Sarah Dewilde, Mathieu F. Janssen, (unknown), Fiammetta Vanoli, Rita Frangiamore, Glenn Phillips, (unknown), Renato Mantegazza, Andreas Meisel, Frauke Stascheit	5
5	Development and validation of the Myasthenia Gravis TeleScore (MGTS) 2022 ·Neurological Sciences ·(unknown), (unknown), (unknown), Mario Ermani, Rita Frangiamore, Fiammetta Vanoli, Carlo Antozzi, Renato Mantegazza, Domenico Marco Bonifati	2
6	Next-Generation Sequencing Identifies Extended HLA Class I and II Haplotypes Associated With Early-Onset and Late-Onset Myasthenia Gravis in Italian, Norwegian, and Swedish Populations 2021 ·Frontiers in Immunology ·Lisa E. Creary, (unknown), Stacy J. Caillier, Paola Cavalcante, Rita Frangiamore, Benedicte A. Lie, Mats Bengtsson, Hanne F. Harbo, Susanna Brauner, Jill A. Hollenbach, Jorge R. Oksenberg, Pia Bernasconi, Angelina Maniaol, Lennart Hammarström, Renato Mantegazza, Marcelo Fernández-Viña	8
7	Iatrogenic Kaposi’s sarcoma in myasthenia gravis: learnings from two case reports 2021 ·Neurological Sciences ·Rita Frangiamore, Riccardo Giossi, Fiammetta Vanoli, Athanasia Tourlaki, Lucia Brambilla, Lorenzo Maggi, Renato Mantegazza	0
8	Complement Inhibition for the Treatment of Myasthenia Gravis 2020 ·SHILAP Revista de lepidopterología ·Renato Mantegazza, Fiammetta Vanoli, Rita Frangiamore, Paola Cavalcante	0
9	<p>Complement Inhibition for the Treatment of Myasthenia Gravis</p> 2020 ·ImmunoTargets and Therapy ·Renato Mantegazza, Fiammetta Vanoli, Rita Frangiamore, Paola Cavalcante	33
10	miR-146a in Myasthenia Gravis Thymus Bridges Innate Immunity With Autoimmunity and Is Linked to Therapeutic Effects of Corticosteroids 2020 ·Frontiers in Immunology ·(unknown), Letizia Scandiffio, Stefania Marcuzzo, Silvia Bonanno, Rita Frangiamore, Teresio Motta, Carlo Antozzi, Renato Mantegazza, Paola Cavalcante, Pia Bernasconi	36
11	Employment in Myasthenia Gravis: A Systematic Literature Review and Meta-Analysis 2020 ·Neuroepidemiology ·Erika Guastafierro, Irene Tramacere, Claudia Toppo, Matilde Leonardi, Renato Mantegazza, Silvia Bonanno, Rita Frangiamore, Alberto Raggi	15
12	Exercise training alone or in combination with high-protein diet in patients with late onset Pompe disease: results of a cross over study 2020 ·Orphanet Journal of Rare Diseases ·Annalisa Sechi, Lucrezia Zuccarelli, Bruno Grassi, Rita Frangiamore, Ramona De Amicis, Mauro Marzorati, Simone Porcelli, Annarita Tullio, (unknown), Simona Bertoli, Andrea Dardis, (unknown), Maria Barbara Pasanisi, Grazia Devigili, Bruno Bembi	23
13	Quantitative Muscle MRI Protocol as Possible Biomarker in Becker Muscular Dystrophy 2020 ·Clinical Neuroradiology ·Lorenzo Maggi, Marco Moscatelli, Rita Frangiamore, (unknown), (unknown), Alberto De Luca, Maria Barbara Pasanisi, Giovanni Baranello, Irene Tramacere, Luisa Chiapparini, Maria Grazia Bruzzone, Renato Mantegazza, Domenico Aquino	15
14	MicroRNA signature associated with treatment response in myasthenia gravis: A further step towards precision medicine 2019 ·Pharmacological Research ·Paola Cavalcante, (unknown), (unknown), Letizia Scandiffio, (unknown), Silvia Bonanno, Rita Frangiamore, Renato Mantegazza, Pia Bernasconi, Talma Brenner, Adi Vaknin‐Dembinsky, Carlo Antozzi	19
15	Amifampridine phosphate in the treatment of muscle-specific kinase myasthenia gravis: a phase IIb, randomized, double-blind, placebo-controlled, double crossover study 2018 ·SAGE Open Medicine ·Silvia Bonanno, Maria Barbara Pasanisi, Rita Frangiamore, Lorenzo Maggi, Carlo Antozzi, Francesca Andreetta, Angela Campanella, Greta Brenna, (unknown), Renato Mantegazza	23
16	Early effect of dalfampridine in patients with MS: A multi-instrumental approach to better investigate responsiveness 2016 ·Journal of the Neurological Sciences ·Laura Brambilla, Davide Rossi Sebastiano, Domenico Aquino, Valentina Torri Clerici, Greta Brenna, Marco Moscatelli, Rita Frangiamore, Ambra Mara Giovannetti, Carlo Antozzi, Renato Mantegazza, Silvana Franceschetti, Maria Grazia Bruzzone, Alessandra Erbetta, Paolo Confalonieri	16
17	Identification of a gene expression signature in peripheral blood of multiple sclerosis patients treated with disease-modifying therapies 2016 ·Clinical Immunology ·Chiara Cordiglieri, Fulvio Baggi, Pia Bernasconi, Dimos Kapetis, Elisa Faggiani, Alessandra Consonni, Francesca Andreetta, Rita Frangiamore, Paolo Confalonieri, Carlo Antozzi, Renato Mantegazza	9
18	A novel ABCC6 haplotype is associated with azathioprine drug response in myasthenia gravis 2016 ·Pharmacogenetics and Genomics ·(unknown), Barbara Galbardi, (unknown), Silvia Bonanno, (unknown), Rita Frangiamore, Giorgia Camera, Maria Foti, (unknown), (unknown), Lorenzo Maggi, Carlo Antozzi, Renato Mantegazza, Pia Bernasconi, Dimos Kapetis	5
19	Cognitive function alone is a poor predictor of health-related quality of life in employed patients with MS: results from a cross-sectional study 2016 ·The Clinical Neuropsychologist ·Ambra Mara Giovannetti, Silvia Schiavolin, Greta Brenna, Laura Brambilla, Paolo Confalonieri, Francesca Cortese, Venusia Covelli, Rita Frangiamore, Matilde Leonardi, Renato Mantegazza, Marco Moscatelli, Michela Ponzio, Valentina Torri Clerici, Paola Zaratin, Alberto Raggi	10
20	Multiple Sclerosis Questionnaire for Job Difficulties (MSQ-Job): definition of the cut-off score 2016 ·Neurological Sciences ·Silvia Schiavolin, Ambra Mara Giovannetti, Matilde Leonardi, Greta Brenna, Laura Brambilla, Paolo Confalonieri, Rita Frangiamore, Renato Mantegazza, Marco Moscatelli, Valentina Torri Clerici, Francesca Cortese, Venusia Covelli, Michela Ponzio, Paola Zaratin, Alberto Raggi	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact